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On the high probability that a perceived lack of 
value of obtaining a p value will be detrimental to 
patient care! 
We are privileged to be invited by the Editor to comment on 
the article by Kanter et al.’ in this issue of TRANSFUSION 
purporting a lack of value in obtaining a p value of c0.05 
(95% confidence level) when performing antibody identifi- 
cation studies. We are especially concerned that the vast 
majority of technologists performing these studies will now 
reject the “3+/3- rule” promulgated by their mentors. This 
can only have a negative impact on patient care. 
Kanter et al. claim that Judd is wrong in stating, “[A] p 
value of 0.05 ... means that an identical set of reactions due 
to an antibody other than D could be obtained by chance 
once in 20 similar studies.”2@2111 They consider Menitove3 
correct in stating that Fisher’s exact test is actually a test for 
statistical independence between test results and the pres- 
ence or absence of a specific antigen. However, in accept- 
ing the null hypothesis, one is stating that the probability of 
obtaining a positive test with antigen-positive red cells 
(RBCs) equals the probability of obtaining a positive test 
with antigen-negative RBCs. In rejecting the null hypothesis, 
one is stating that the reactions with antigen-positive RBCs 
and antigen-negative RBCs have different underlying prob- 
abilities. In this sense, the statement of Menitove3 is correct. 
However, the p value, or the level of significance, is also “the 
probability of rejecting a true null hypothesis.” In this sense, 
Judd is also correctn2 If the null hypothesis is indeed true, 
then p is the probability of obtaining the observed results 
by chance. 
While one can argue the “science” of statistics, it is im- 
perative not to lose sight of the fact that application of the 
3+/3- rule is but one of several measures used to enhance 
the quality-and hence, the accuracy-of antibody identi- 
fication. In addition to validating negative antiglobulin tests 
with IgG-coated RBCs, other measures (notable exceptions 
aside) include confirming 1) that the test phase of reactivity 
is consistent with the concluded specificity; 2) that the an- 
TABLE 1. Influence of test sensltlvlty and speclflclty 
on probeblllty of correct ldentlflcetlon 
Sensitivity Specificity 3+/3- rule 2+/2- rule 
0.95 0.95 0.954 (46)’ 0.858 (142) 
0.757 0.95 0.929 (71) 0.826 (174) 
0.95 0.75$ 0.591 (409) 0.429 (571) 
Probability of correct identification and expected number of in- 
correct antlbody identifications in parentheses, including feiiure 
to identify en antibody that is present, per 1000 studies. 
t High number of false negatives as in improper incubation con- 
ditions. * High number of false positives as seen wlth interference from 
additional (unidentified) antibodies, autoantibodies, end false 
reactivity. 
tigen to which the serum is deemed to contain alloantibody 
is absent from the autologous RBCs; 3) that the concluded 
specificity is consistent with results of the initial antibody 
detection tests; and 4) that units lacking antigens to which 
the serum is deemed to contain antibody are crossmatch- 
compatible. Further, most workers utilize reagent RBC pan- 
els of 8 to 11 samples, and the confidence level obtained is 
often far greater than 95 percent. However, the 3+/3- rule 
do become important when multiple antibodies are 
present and the numbers of positive and negative samples 
are limited. 
In calculations of the probability that a particular anti- 
body is present, the sensitivity and specificity of the test 
method employed also must be taken into consideration. 
The probability (call it p) that a positive test with an antigen- 
positive RBC sample is a true positive (i.e., is due to the pres- 
ence of specific antibody) is equal to the predictive value of 
a positive test. The probability (call it q) that a negative test 
is a true negative is equal to the specificity of the method 
used. Assuming that individual serologic tests are indepen- 
dent, the probability that the decision rule will be met is 
given by the formula r = (141 - p)”) (1 - (1 - q)”), where n is 
the number of antigen-positive and antigen-negative RBC 
samples used (e.g., 2 or 3). The rate of identification failures 
per 1000 samples is given by lOOO(l-r).Table 1 gives the like- 
lihood that an antibody is present given either a 3+/3- rule 
(criterion used by US workers) or a 2+/2- rule (UK re- 
quirement), assuming different levels of test sensitivity and 
specificity It is evident that using 2 antigen-positive and 2 
antigen-negative RBC samples significantly reduce the con- 
fidence one can have in antibody identification even with 
excellent test performance. 
We have seen the consequences of too many mis- 
identified antibodies not to come to believe that it would be 
less than prudent to encourage workers to forget the 3+/3- 
rule or any of the other quality assurance measures that are 
part of good laboratory practice. 
W. John Judd, FIBMS, MIBiol 
Robertson Davenport, MD 
University of Michigan 
AnnArbor, MI 
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